Literature DB >> 16039605

The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse.

Ruben Schechter1, Delia Beju, Kenneth E Miller.   

Abstract

Complications of diabetes mellitus within the nervous system are peripheral and central neuropathy. In peripheral neuropathy, defects in neurofilament and microtubules have been demonstrated. In this study, we examined the effects of insulin deficiency within the brain in insulin knockout mice (I-/-). The I-/- exhibited hyperphosphorylation of tau, at threonine 231, and neurofilament. In addition, we showed hyperphosphorylation of c-Jun N-terminal kinase (JNK) and glycogen synthase kinase 3 beta (GSK-3 beta) at serine 9. Extracellular signal-regulated kinase 1 (ERK 1) showed decrease in phosphorylation, whereas ERK 2 showed no changes. Ultrastructural examination demonstrated swollen mitochondria, endoplasmic reticulum, and Golgi apparatus, and dispersion of the nuclear chromatin. Microtubules showed decrease in the number of intermicrotubule bridges and neurofilament presented as bunches. Thus, lack of insulin brain stimulation induces JNK hyperphosphorylation followed by hyperphosphorylation of tau and neurofilament, and ultrastructural cellular damage, that over time may induce decrease in cognition and learning disabilities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16039605     DOI: 10.1016/j.bbrc.2005.07.001

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

Review 1.  The study of Golgi apparatus in Alzheimer's disease.

Authors:  Zhiping Hu; Liuwang Zeng; Zhiling Huang; Jie Zhang; Ting Li
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

2.  Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes.

Authors:  Serena Abbondante; David Baglietto-Vargas; Carlos J Rodriguez-Ortiz; Tatiana Estrada-Hernandez; Rodrigo Medeiros; Frank M Laferla
Journal:  Am J Pathol       Date:  2014-01-07       Impact factor: 4.307

3.  Presenilin-1 regulates induction of hypoxia inducible factor-1α: altered activation by a mutation associated with familial Alzheimer's disease.

Authors:  Rita De Gasperi; Miguel A Gama Sosa; Stella Dracheva; Gregory A Elder
Journal:  Mol Neurodegener       Date:  2010-09-23       Impact factor: 14.195

Review 4.  Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia.

Authors:  Hiroyuki Umegaki
Journal:  Drugs Aging       Date:  2016-06       Impact factor: 3.923

Review 5.  Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.

Authors:  Rasoul Ghasemi; Leila Dargahi; Ali Haeri; Maryam Moosavi; Zahurin Mohamed; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2013-01-20       Impact factor: 5.590

6.  Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes.

Authors:  Bhumsoo Kim; Carey Backus; Sangsu Oh; John M Hayes; Eva L Feldman
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

7.  Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease.

Authors:  Yanqiu Deng; Bin Li; Fei Liu; Khalid Iqbal; Inge Grundke-Iqbal; Roland Brandt; Cheng-Xin Gong
Journal:  FASEB J       Date:  2007-08-08       Impact factor: 5.191

Review 8.  Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain.

Authors:  D Allan Butterfield; Fabio Di Domenico; Eugenio Barone
Journal:  Biochim Biophys Acta       Date:  2014-06-17

9.  Structural and ultrastructural analysis of cerebral cortex, cerebellum, and hypothalamus from diabetic rats.

Authors:  Juan P Hernández-Fonseca; Jaimar Rincón; Adriana Pedreañez; Ninoska Viera; José L Arcaya; Edgardo Carrizo; Jesús Mosquera
Journal:  Exp Diabetes Res       Date:  2009-10-01

10.  Recent challenges in insulin delivery systems: a review.

Authors:  M M Al-Tabakha; A I Arida
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.